AnalystBook Research · Company Intelligence

EMBRAER S.A.

EMBJNYSE

Built from EMBRAER S.A.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

← Research LibraryThe BriefFY2025 20-F · headline figures audited against SEC data

Embraer grew revenue 18.5% to $7.58B on more jet deliveries and defense work and lifted its backlog to $31.6 billion, but operating margin fell 242 bps to 8.02% and net income was flat at $351.9M

The read at a glance✓ Audited against SEC data
  • Growth — Revenue up 18.5% to $7.58B; all five segments grewOK
  • Profitability — Operating margin down 242 bps to 8.02%; net income $351.9M, down 0.2%Watch
  • Balance sheet — Cash $1,950M; 2028 notes refinanced into 2038 notes; equity up 12.0%Note
  • Accounting quality — Distress-zone balance-sheet screen on FY2023 figures; other screens not availableWatch
  • Capital allocation — Repurchased 10,800,000 shares in late 2025; distributions resumed for 2025 profitsNote
  • Order backlog — Firm backlog $31.6 billion, from $26.3 billion; 1,001 aircraftOK

Business

Embraer, formed by the Brazilian government in 1969 and privatized in 1994, is the leading maker of jets with up to 150 seats, with a 30% share of accumulated deliveries since 2004. It sells E175 and E2 regional jets to airlines, Phenom and Praetor business jets, the KC-390 Millennium transport and A-29 Super Tucano to air forces, and services to the fleet it has built. It owns 72.7% of Eve, which is developing an electric vertical take-off aircraft. Reports are in U.S. dollars under IFRS.

Latest filings

  • 6-K · Company announcement (foreign filer)2026-10-02
  • 6-K · Company announcement (foreign filer)2026-10-01
  • 6-K · Company announcement (foreign filer)2026-10-01
  • 6-K · Company announcement (foreign filer)2026-09-04
  • 6-K · Company announcement (foreign filer)2026-08-20
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about EMBRAER S.A., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

See the full EMBJ record — start free

14-day free trial, no credit card. For research purposes only; not investment advice.